URGN - UroGen Pharma Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.50
DETAILS
HIGH:
$45.00
LOW:
$40.00
MEDIAN:
$42.50
CONSENSUS:
$42.50
UPSIDE:
47.11%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,023,159 | $18.4M | 0.0% | +60,535 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-08 | Schoenberg Mark | officer: Chief Medical Officer | SELL | 10,000 | $30.00 | $300K |
| 2025-02-26 | Robinson James A. Jr. | director | M-Exempt | 2,000 | -- | -- |
| 2026-01-31 | Barrett Elizabeth A. | officer: Chief Executive Officer | A-Award | 153,195 | -- | -- |
| 2026-02-03 | Smith Jason Drew | officer: General Counsel | SELL | 1,608 | $19.69 | $32K |
| 2026-01-31 | Smith Jason Drew | officer: General Counsel | M-Exempt | 3,333 | -- | -- |
| 2026-01-31 | Smith Jason Drew | officer: General Counsel | A-Award | 32,609 | -- | -- |
| 2026-01-31 | Smith Jason Drew | officer: General Counsel | M-Exempt | 6,667 | -- | -- |
| 2026-01-31 | Smith Jason Drew | officer: General Counsel | M-Exempt | 5,500 | -- | -- |
| 2026-02-03 | Smith Jason Drew | officer: General Counsel | SELL | 3,217 | $19.69 | $63K |
| 2026-02-03 | Smith Jason Drew | officer: General Counsel | SELL | 2,654 | $19.69 | $52K |
| 2026-02-03 | Schoenberg Mark | officer: Chief Medical Officer | SELL | 3,686 | $19.69 | $73K |
| 2026-02-03 | Schoenberg Mark | officer: Chief Medical Officer | SELL | 1,843 | $19.69 | $36K |
| 2026-02-03 | Schoenberg Mark | officer: Chief Medical Officer | SELL | 1,844 | $19.69 | $36K |
| 2026-01-31 | Schoenberg Mark | officer: Chief Medical Officer | M-Exempt | 3,333 | -- | -- |
| 2026-01-31 | Schoenberg Mark | officer: Chief Medical Officer | M-Exempt | 3,334 | -- | -- |
| 2026-01-31 | Schoenberg Mark | officer: Chief Medical Officer | A-Award | 20,000 | -- | -- |
| 2026-01-31 | Schoenberg Mark | officer: Chief Medical Officer | M-Exempt | 6,666 | -- | -- |
| 2026-01-31 | Degnan Chris | officer: Chief Financial Officer | A-Award | 32,609 | -- | -- |
| 2025-11-26 | Holden Stuart | director | M-Exempt | 2,000 | -- | -- |
| 2025-11-26 | BUTITTA CYNTHIA M | director | M-Exempt | 2,000 | -- | -- |
| 2025-11-26 | Robinson James A. Jr. | director | M-Exempt | 2,000 | -- | -- |
| 2025-11-26 | WEN LEANA | director | M-Exempt | 2,000 | -- | -- |
| 2025-11-26 | Wildman Daniel George | director | M-Exempt | 2,000 | -- | -- |
| 2025-11-19 | Schoenberg Mark | officer: Chief Medical Officer | SELL | 10,000 | $25.00 | $250K |
| 2025-10-08 | Degnan Chris | officer: Chief Financial Officer | SELL | 2,203 | $16.85 | $37K |